Y
Yasuhiro Tamaki
Researcher at University of Tokyo
Publications - 143
Citations - 4976
Yasuhiro Tamaki is an academic researcher from University of Tokyo. The author has contributed to research in topics: Choroidal neovascularization & Retinal. The author has an hindex of 38, co-authored 143 publications receiving 4652 citations. Previous affiliations of Yasuhiro Tamaki include Manhattan Eye, Ear and Throat Hospital.
Papers
More filters
Journal ArticleDOI
Light-induced gene transfer from packaged DNA enveloped in a dendrimeric photosensitizer
Nobuhiro Nishiyama,Aya Iriyama,Woo Dong Jang,Kanjiro Miyata,Keiji Itaka,Yuji Inoue,Hidenori Takahashi,Yasuo Yanagi,Yasuhiro Tamaki,Hiroyuki Koyama,Kazunori Kataoka +10 more
TL;DR: This work demonstrates a new biomedical application for dendrimers, and the first success in the photochemical-internalization-mediated gene delivery in vivo, in which these two components are assembled into one structure.
Journal ArticleDOI
Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration.
Yuji Inoue,Aya Iriyama,Shuji Ueno,Hidenori Takahashi,Mineo Kondo,Yasuhiro Tamaki,Makoto Araie,Yasuo Yanagi +7 more
TL;DR: Results suggest that MSC is a useful cell source for cell-replacement therapy for some forms of retinal degeneration, and secreted factor(s) from the MSCs promote photoreceptor cell survival.
Journal Article
Noncontact, two-dimensional measurement of retinal microcirculation using laser speckle phenomenon.
TL;DR: A new apparatus for noncontact, two-dimensional measurement of retinal microcirculation using the laser speckle phenomenon is reported and it is demonstrated that this apparatus can document known or expected changes in retinal blood flow.
Journal ArticleDOI
Non-contact, two-dimensional measurement of tissue circulation in choroid and optic nerve head using laser speckle phenomenon.
TL;DR: The results suggest that by using the present apparatus, the blood velocity in the choroid or ONH under various conditions can be studied non-invasively in the living eye.
Journal ArticleDOI
Nanotechnology-based photodynamic therapy for neovascular disease using a supramolecular nanocarrier loaded with a dendritic photosensitizer.
Ryuichi Ideta,Fumitaka Tasaka,Woo Dong Jang,Nobuhiro Nishiyama,Guodong Zhang,Atsushi Harada,Yasuo Yanagi,Yasuhiro Tamaki,Takuzo Aida,Kazunori Kataoka +9 more
TL;DR: With its highly selective accumulation on choroidal neovascularization (CNV) lesions, this treatment resulted in a remarkably efficacious CNV occlusion with minimal unfavorable phototoxicity.